Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ikonisys becomes distributor of oncoFISH cancer test

This article was originally published in Clinica

Executive Summary

Ikonisys has become the distributor of Clinical Laboratory Partners’ oncoFISH cervical cancer test as part of an exclusive licensing deal. The assay is a companion test designed to work alongside existing cervical cancer screening tests like Pap smear and HPV tests prior to colposcopy. Under the terms of the partnership, Newington, Connecticut-based Clinical Laboratory Partners will market the assay to physicians for the analysis of specimens from liquid-based Pap tests classified as low-grade squamous intraepithelial lesion (LSIL). Ikonisys (New Haven, Connecticut) will conduct the evaluation of the specimen using its Ikoniscope digital microscopy system. The oncoFISH test will assist in determining if there is a risk of progression to cervical cancer or if the lesion will naturally regress, by identifying a genetic marker linked to increased likelihood of cervical cancer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel